EXECUTIVE ENGAGEMENTS
POOL
INTERACTIONS
PARTICIPANTS
VALIDATIONS
COMPANIES
* Login for a full stack data experience
DATE
JAN 2022
TABLES
123
PAGES
196
EDITION
6
PRICE
USD 4950
CODE
MCP13899
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
SELECT PLAYERS
Biomatrik; Celares GmbH; Creative PEGWorks; Iris Biotech GmbH; Jenkem Technology Co., Ltd.; Laysan Bio, Inc.; MilliporeSigma; Nof American Corporation; Quanta Biodesign, Ltd.; Thermo Fisher Scientific, Inc.
SEGMENTS
» End-Use (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic Research Institutes) » Product (Consumables, Services) » Protein Type (Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII, Other Protein Types)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
I. METHODOLOGY |
II. EXECUTIVE SUMMARY |
1. MARKET OVERVIEW |
Influencer Market Insights |
World Market Trajectories |
Impact of Covid-19 and a Looming Global Recession |
2. FOCUS ON SELECT PLAYERS |
3. MARKET TRENDS & DRIVERS |
4. GLOBAL MARKET PERSPECTIVE |
World Current & Future Analysis for PEGylated Proteins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR |
World Historic Review for PEGylated Proteins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
World 15-Year Perspective for PEGylated Proteins by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2018 & 2027 |
World Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR |
World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
World Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR |
World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
World Current & Future Analysis for Colony Stimulating Factors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR |
World Historic Review for Colony Stimulating Factors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
World 15-Year Perspective for Colony Stimulating Factors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
World Current & Future Analysis for Interferons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR |
World Historic Review for Interferons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
World 15-Year Perspective for Interferons by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
World Current & Future Analysis for Erythropoietin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR |
World Historic Review for Erythropoietin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
World 15-Year Perspective for Erythropoietin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
World Current & Future Analysis for mAbs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR |
World Historic Review for mAbs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
World 15-Year Perspective for mAbs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
World Current & Future Analysis for Recombinant Factor VIII by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR |
World Historic Review for Recombinant Factor VIII by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
World 15-Year Perspective for Recombinant Factor VIII by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
World Current & Future Analysis for Other Protein Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR |
World Historic Review for Other Protein Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
World 15-Year Perspective for Other Protein Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
World Current & Future Analysis for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR |
World Historic Review for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
World 15-Year Perspective for Pharmaceutical & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
World Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR |
World Historic Review for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
World 15-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
World Current & Future Analysis for Academic Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR |
World Historic Review for Academic Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
World 15-Year Perspective for Academic Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027 |
III. MARKET ANALYSIS |
UNITED STATES |
USA Current & Future Analysis for PEGylated Proteins by Product - Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
USA Historic Review for PEGylated Proteins by Product - Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
USA 15-Year Perspective for PEGylated Proteins by Product - Percentage Breakdown of Value Sales for Consumables and Services for the Years 2012, 2018 & 2027 |
USA Current & Future Analysis for PEGylated Proteins by Protein Type - Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
USA Historic Review for PEGylated Proteins by Protein Type - Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
USA 15-Year Perspective for PEGylated Proteins by Protein Type - Percentage Breakdown of Value Sales for Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types for the Years 2012, 2018 & 2027 |
USA Current & Future Analysis for PEGylated Proteins by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
USA Historic Review for PEGylated Proteins by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
USA 15-Year Perspective for PEGylated Proteins by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes for the Years 2012, 2018 & 2027 |
CANADA |
Canada Current & Future Analysis for PEGylated Proteins by Product - Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
Canada Historic Review for PEGylated Proteins by Product - Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
Canada 15-Year Perspective for PEGylated Proteins by Product - Percentage Breakdown of Value Sales for Consumables and Services for the Years 2012, 2018 & 2027 |
Canada Current & Future Analysis for PEGylated Proteins by Protein Type - Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
Canada Historic Review for PEGylated Proteins by Protein Type - Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
Canada 15-Year Perspective for PEGylated Proteins by Protein Type - Percentage Breakdown of Value Sales for Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types for the Years 2012, 2018 & 2027 |
Canada Current & Future Analysis for PEGylated Proteins by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
Canada Historic Review for PEGylated Proteins by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
Canada 15-Year Perspective for PEGylated Proteins by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes for the Years 2012, 2018 & 2027 |
JAPAN |
Japan Current & Future Analysis for PEGylated Proteins by Product - Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
Japan Historic Review for PEGylated Proteins by Product - Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
Japan 15-Year Perspective for PEGylated Proteins by Product - Percentage Breakdown of Value Sales for Consumables and Services for the Years 2012, 2018 & 2027 |
Japan Current & Future Analysis for PEGylated Proteins by Protein Type - Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
Japan Historic Review for PEGylated Proteins by Protein Type - Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
Japan 15-Year Perspective for PEGylated Proteins by Protein Type - Percentage Breakdown of Value Sales for Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types for the Years 2012, 2018 & 2027 |
Japan Current & Future Analysis for PEGylated Proteins by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
Japan Historic Review for PEGylated Proteins by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
Japan 15-Year Perspective for PEGylated Proteins by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes for the Years 2012, 2018 & 2027 |
CHINA |
China Current & Future Analysis for PEGylated Proteins by Product - Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
China Historic Review for PEGylated Proteins by Product - Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
China 15-Year Perspective for PEGylated Proteins by Product - Percentage Breakdown of Value Sales for Consumables and Services for the Years 2012, 2018 & 2027 |
China Current & Future Analysis for PEGylated Proteins by Protein Type - Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
China Historic Review for PEGylated Proteins by Protein Type - Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
China 15-Year Perspective for PEGylated Proteins by Protein Type - Percentage Breakdown of Value Sales for Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types for the Years 2012, 2018 & 2027 |
China Current & Future Analysis for PEGylated Proteins by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
China Historic Review for PEGylated Proteins by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
China 15-Year Perspective for PEGylated Proteins by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes for the Years 2012, 2018 & 2027 |
EUROPE |
Europe Current & Future Analysis for PEGylated Proteins by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027 and % CAGR |
Europe Historic Review for PEGylated Proteins by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
Europe 15-Year Perspective for PEGylated Proteins by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2018 & 2027 |
Europe Current & Future Analysis for PEGylated Proteins by Product - Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
Europe Historic Review for PEGylated Proteins by Product - Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
Europe 15-Year Perspective for PEGylated Proteins by Product - Percentage Breakdown of Value Sales for Consumables and Services for the Years 2012, 2018 & 2027 |
Europe Current & Future Analysis for PEGylated Proteins by Protein Type - Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
Europe Historic Review for PEGylated Proteins by Protein Type - Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
Europe 15-Year Perspective for PEGylated Proteins by Protein Type - Percentage Breakdown of Value Sales for Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types for the Years 2012, 2018 & 2027 |
Europe Current & Future Analysis for PEGylated Proteins by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
Europe Historic Review for PEGylated Proteins by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
Europe 15-Year Perspective for PEGylated Proteins by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes for the Years 2012, 2018 & 2027 |
FRANCE |
France Current & Future Analysis for PEGylated Proteins by Product - Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
France Historic Review for PEGylated Proteins by Product - Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
France 15-Year Perspective for PEGylated Proteins by Product - Percentage Breakdown of Value Sales for Consumables and Services for the Years 2012, 2018 & 2027 |
France Current & Future Analysis for PEGylated Proteins by Protein Type - Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
France Historic Review for PEGylated Proteins by Protein Type - Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
France 15-Year Perspective for PEGylated Proteins by Protein Type - Percentage Breakdown of Value Sales for Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types for the Years 2012, 2018 & 2027 |
France Current & Future Analysis for PEGylated Proteins by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
France Historic Review for PEGylated Proteins by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
France 15-Year Perspective for PEGylated Proteins by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes for the Years 2012, 2018 & 2027 |
GERMANY |
Germany Current & Future Analysis for PEGylated Proteins by Product - Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
Germany Historic Review for PEGylated Proteins by Product - Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
Germany 15-Year Perspective for PEGylated Proteins by Product - Percentage Breakdown of Value Sales for Consumables and Services for the Years 2012, 2018 & 2027 |
Germany Current & Future Analysis for PEGylated Proteins by Protein Type - Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
Germany Historic Review for PEGylated Proteins by Protein Type - Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
Germany 15-Year Perspective for PEGylated Proteins by Protein Type - Percentage Breakdown of Value Sales for Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types for the Years 2012, 2018 & 2027 |
Germany Current & Future Analysis for PEGylated Proteins by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
Germany Historic Review for PEGylated Proteins by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
Germany 15-Year Perspective for PEGylated Proteins by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes for the Years 2012, 2018 & 2027 |
ITALY |
Italy Current & Future Analysis for PEGylated Proteins by Product - Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
Italy Historic Review for PEGylated Proteins by Product - Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
Italy 15-Year Perspective for PEGylated Proteins by Product - Percentage Breakdown of Value Sales for Consumables and Services for the Years 2012, 2018 & 2027 |
Italy Current & Future Analysis for PEGylated Proteins by Protein Type - Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
Italy Historic Review for PEGylated Proteins by Protein Type - Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
Italy 15-Year Perspective for PEGylated Proteins by Protein Type - Percentage Breakdown of Value Sales for Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types for the Years 2012, 2018 & 2027 |
Italy Current & Future Analysis for PEGylated Proteins by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
Italy Historic Review for PEGylated Proteins by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
Italy 15-Year Perspective for PEGylated Proteins by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes for the Years 2012, 2018 & 2027 |
UNITED KINGDOM |
UK Current & Future Analysis for PEGylated Proteins by Product - Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
UK Historic Review for PEGylated Proteins by Product - Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
UK 15-Year Perspective for PEGylated Proteins by Product - Percentage Breakdown of Value Sales for Consumables and Services for the Years 2012, 2018 & 2027 |
UK Current & Future Analysis for PEGylated Proteins by Protein Type - Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
UK Historic Review for PEGylated Proteins by Protein Type - Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
UK 15-Year Perspective for PEGylated Proteins by Protein Type - Percentage Breakdown of Value Sales for Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types for the Years 2012, 2018 & 2027 |
UK Current & Future Analysis for PEGylated Proteins by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
UK Historic Review for PEGylated Proteins by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
UK 15-Year Perspective for PEGylated Proteins by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes for the Years 2012, 2018 & 2027 |
REST OF EUROPE |
Rest of Europe Current & Future Analysis for PEGylated Proteins by Product - Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
Rest of Europe Historic Review for PEGylated Proteins by Product - Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
Rest of Europe 15-Year Perspective for PEGylated Proteins by Product - Percentage Breakdown of Value Sales for Consumables and Services for the Years 2012, 2018 & 2027 |
Rest of Europe Current & Future Analysis for PEGylated Proteins by Protein Type - Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
Rest of Europe Historic Review for PEGylated Proteins by Protein Type - Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
Rest of Europe 15-Year Perspective for PEGylated Proteins by Protein Type - Percentage Breakdown of Value Sales for Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types for the Years 2012, 2018 & 2027 |
Rest of Europe Current & Future Analysis for PEGylated Proteins by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
Rest of Europe Historic Review for PEGylated Proteins by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
Rest of Europe 15-Year Perspective for PEGylated Proteins by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes for the Years 2012, 2018 & 2027 |
ASIA-PACIFIC |
Asia-Pacific Current & Future Analysis for PEGylated Proteins by Product - Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
Asia-Pacific Historic Review for PEGylated Proteins by Product - Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
Asia-Pacific 15-Year Perspective for PEGylated Proteins by Product - Percentage Breakdown of Value Sales for Consumables and Services for the Years 2012, 2018 & 2027 |
Asia-Pacific Current & Future Analysis for PEGylated Proteins by Protein Type - Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
Asia-Pacific Historic Review for PEGylated Proteins by Protein Type - Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
Asia-Pacific 15-Year Perspective for PEGylated Proteins by Protein Type - Percentage Breakdown of Value Sales for Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types for the Years 2012, 2018 & 2027 |
Asia-Pacific Current & Future Analysis for PEGylated Proteins by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
Asia-Pacific Historic Review for PEGylated Proteins by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
Asia-Pacific 15-Year Perspective for PEGylated Proteins by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes for the Years 2012, 2018 & 2027 |
REST OF WORLD |
Rest of World Current & Future Analysis for PEGylated Proteins by Product - Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
Rest of World Historic Review for PEGylated Proteins by Product - Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
Rest of World 15-Year Perspective for PEGylated Proteins by Product - Percentage Breakdown of Value Sales for Consumables and Services for the Years 2012, 2018 & 2027 |
Rest of World Current & Future Analysis for PEGylated Proteins by Protein Type - Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
Rest of World Historic Review for PEGylated Proteins by Protein Type - Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
Rest of World 15-Year Perspective for PEGylated Proteins by Protein Type - Percentage Breakdown of Value Sales for Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VIII and Other Protein Types for the Years 2012, 2018 & 2027 |
Rest of World Current & Future Analysis for PEGylated Proteins by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027 and % CAGR |
Rest of World Historic Review for PEGylated Proteins by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017 and % CAGR |
Rest of World 15-Year Perspective for PEGylated Proteins by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic Research Institutes for the Years 2012, 2018 & 2027 |
IV. COMPETITION |
Total Companies Profiled: 46 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com